Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome

International Journal of Geriatric Psychiatry

Volumn 20, Issue 5, 2005, Pages 496-497

  Prasher, V P ^a   Fung, N ^b   Adams, C ^a  

^a Queen Elizabeth Psychiatric Hospital ^*  (United Kingdom)

^b QUEEN ELIZABETH PSYCHIATRIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RIVASTIGMINE;

ADAPTIVE BEHAVIOR; ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIARRHEA; DISEASE SEVERITY; DOWN SYNDROME; FATIGUE; HUMAN; INSOMNIA; INTERVIEW; NAUSEA AND VOMITING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; DOWN SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PHENYLCARBAMATES; TREATMENT OUTCOME;

EID: 19144364648     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1306     Document Type: Article

References (8)

1. Kishnani PS, Sullivan JA, Walter BK, Spiridigliozzi GA, Doraiswamy PM, Krishnan KR. 1999. Cholinergic therapy for Down's syndrome. Lancet 353: 1064-1065.
2. Lott IT, Osann K, Doran E, Nelson L. 2002. Down Syndrome and Alzheimer's Disease: response to Donepezil. Arch Neurol 59: 1133-1136.
3. National Institute for Clinical Excellence. 2001. Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer's disease. Technology and Appraisal Guidance no. 19.
4. Prasher VP. 1995. Age-specific prevalence, thyroid dysfunction and depressive symptomatology in adults with Down syndrome and dementia. Int J Geriatr Psychiatry 10: 25-31.
5. Prasher VP, Huxley A, Haque MS. 2002. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease - Pilot study. Int J Geriatr Psychiatry 17: 270-278.
6. Prasher VP. 2004. Review of donepezil, rivastigmine, galanatamine and memantine for the treatment of dementia in AD in adults with Down syndrome: implications for the intellectual disability population. Int J Geriatr Psychiatry 19: 1-7.
7. World Health Organisation. 1993. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. WHO: Geneva.
8. World Health Organisation. 1994. ICD-10 Symptom Checklist for Mental Disorders. Version 1.1. WHO: Geneva.